U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354906) titled 'Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.' on Jan. 12.
Brief Summary: Participants will be followed as part of the usual management of their disease. No modifications will be made (no additional visits, examinations, or questionnaires). The safety and well-being of participants will therefore remain unchanged.
The participant will be informed about the study during one of their routine care visits. The information will be provided by the investigator, and the participant's non-opposition to participation in the study will be obtained.
The participant will continue to be followed as part of th...